Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q3 2025
Harvard Apparatus Regenerative Technology (HRGN) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $123K for the third quarter 2025 (Q3 2025), +108% from a year earlier and -61% from the quarter before.
Harvard Apparatus Regenerative Technology, Q3 2025: revenue $123K (+108% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $123K | -61% | +108% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.5M | — | — |
What changed
Revenue was $123K in Q3 2025, up 108% year over year and down 61% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -1393.5%. Total costs fell 4% while revenue rose 108%. The fastest-growing cost line was Cost of revenue (+60%). The quarter ended with a net loss of $1.7M, narrower than the previous quarter's $1.8M loss.
Operating cash flow was −$1.5M. Non-cash charges added back $1K of depreciation and $495K of share-based compensation. Working capital and other items used $261K.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the third quarter 2025?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $123K for the third quarter 2025 (Q3 2025), +108% from a year earlier and -61% from the quarter before.
Source: Harvard Apparatus Regenerative Technology 10-Q on SEC EDGAR.